|
|
Autism Research Institute
Autism Research Review International
1987 to 2004, Volumes 1 to 18
O
Oakland (CA), 1997, Vol. 11(4) pp. 2
obesity, 1997, Vol. 11(3) pp. 2
obsessive behaviors, 1997, Vol. 11(1) pp. 2; 1997, Vol. 11(2) pp. 7; 2002, Vol. 16(4) pp. 4. See also fixations
obsessive-compulsive disorder (OCD)
behavior modification for, 1996, Vol. 10(1) pp. 5
and Borna virus, 1996, Vol. 10(3) pp. 5; 1997, Vol. 11(2) pp. 2.
brain abnormalities of, 1996, Vol. 10(1) pp. 5
Delta (9)-THC (tetrahydrocannabinol) for, 2003, Vol. 17(1) pp. 4
drugs and, 1994, Vol. 08(3) pp. 4; 1995, Vol. 09(2) pp. 7; 1996, Vol. 10(2) pp. 4; 1996, Vol. 10(3) pp. 2; 1998, Vol. 12(4) pp. 2; 2003, Vol. 17(3) pp. 7.
drugs (anti-depressants) and, 1991, Vol. 05(1) pp. 4; 1991, Vol. 05(4) pp. 1; 1992, Vol. 06(2) pp. 7; 1992, Vol. 06(4) pp. 5; 1993, Vol. 07(3) pp. 1; 1995, Vol. 09(4) pp. 1; 1997, Vol. 11(2) pp. 1.
eicosapentaenoic acid (EPA) for, 2003, Vol. 17(4) pp. 2
and Epstein-Barr, 2001, Vol. 15(1) pp. 4
and herpes simplex, 1997, Vol. 11(2) pp. 2
intravenous immunoglobulin (IVIG) therapy for, 1996, Vol. 10(3) pp. 1; 1999, Vol. 13(3) pp. 7.
marijuana for, 2002, Vol. 16(2) pp. 7
and mercury poisoning, 2000, Vol. 14(2) pp. 7
and PDD, 1996, Vol. 10(4) pp. 2
plasmapheresis for, 1999, Vol. 13(3) pp. 7
serotonin and, 1992, Vol. 06(2) pp. 7; 1994, Vol. 08(3) pp. 4.
and strep, 1996, Vol. 10(3) pp. 1; 1997, Vol. 11(2) pp. 2; 1998, Vol. 12(2) pp. 2; 2002, Vol. 16(1) pp. 4.
supplements (DMG) for, 1995, Vol. 09(2) pp. 7; 1996, Vol. 10(3) pp. 7.
supplements for, 2002, Vol. 16(4) pp. 4
supplements (inosolitol) for, 1997, Vol. 11(2) pp. 1–2
supplements (St. John's wort) for, 2001, Vol. 15(1) pp. 5
supplements (vitamin B3) for, 2002, Vol. 16(4) pp. 4
Tourette's and, 1991, Vol. 05(3) pp. 1; 1995, Vol. 09(4) pp. 4.
obsessive thoughts
occipital lobe, 2001, Vol. 15(2) pp. 4
Ochs, Cindy, 1993, Vol. 07(2) pp. 2; 1997, Vol. 11(1) pp. 3.
O.D. Heck Developomental Center, 1992, Vol. 06(4) pp. 2
Odom, Samuel, 1988, Vol. 02(1) pp. 7; 1991, Vol. 05(4) pp. 5.
Oepen, G., 1988, Vol. 02(2) pp. 7
Office of Education, U.S., 1993, Vol. 07(4) pp. 3; 2002, Vol. 16(4) pp. 1.
Office of Human Subjects Protection, 2004, Vol. 18(2) pp. 6
O'Hara, Helen, 1994, Vol. 08(1) pp. 7
Ohio, 2004, Vol. 18(4) pp. 3
olanzapine (Zyprexa)
and anxiety, 2001, Vol. 15(1) pp. 4
and diabetes, 1999, Vol. 13(3) pp. 2; 2002, Vol. 16(2) pp. 6; 2002, Vol. 16(4) pp. 6; 2003, Vol. 17(3) pp. 2; 2004, Vol. 18(2) pp. 2.
for PDD symptoms, 1999, Vol. 13(3) pp. 4
for self-injury, 2001, Vol. 15(1) pp. 4
tremors from, 1999, Vol. 13(3) pp. 4
Olden, Kenneth, 2000, Vol. 14(4) pp. 3
O'Leary, John, 1998, Vol. 12(4) pp. 1; 2000, Vol. 14(2) pp. 7; 2001, Vol. 15(3) pp. 2; 2002, Vol. 16(1) pp. 1; 2002, Vol. 16(2) pp. 1.
oligoantigenic diet, 1995, Vol. 09(4) pp. 3
olivary body, 1987, Vol. 01(1) pp. 1
Oliver, Chris, 1993, Vol. 07(2) pp. 5
Olsson, Bo, 1987, Vol. 01(2) pp. 7; 1987, Vol. 01(3) pp. 7.
omega-3-fatty acids. See also eicosapentaenoic acid, HUFAs (highly unsaturated fatty acids)
DHA (See DHA)
for ear infections, 2002, Vol. 16(3) pp. 7
eicosapentaenoic acid for obsessive-compulsive behaviors, 2003, Vol. 17(4) pp. 2
for inflammatory bowel disease in autistics, 2002, Vol. 16(2) pp. 4
for mental illness, 1999, Vol. 13(1) pp. 7
nutritional spread for seizures, 2002, Vol. 16(3) pp. 4
for sleep problems, 1999, Vol. 13(1) pp. 7
for social awareness, 2000, Vol. 14(4) pp. 6
for tantrums, 1999, Vol. 13(1) pp. 7
onset of autism, 1988, Vol. 02(1) pp. 4; 1994, Vol. 08(2) pp. 7; 1994, Vol. 08(4) pp. 4; 2000, Vol. 14(1) pp. 3.
operant conditioning, 1992, Vol. 06(3) pp. 3; 1994, Vol. 08(1) pp. 2; 1994, Vol. 08(3) pp. 3.
opioids
cognitive impairment and, 1987, Vol. 01(2) pp. 6
and melatonin, 1992, Vol. 06(2) pp. 2
and naltrexone, 1987, Vol. 01(2) pp. 1; 1989, Vol. 03(3) pp. 1; 1990, Vol. 04(1) pp. 1; 1992, Vol. 06(1) pp. 1; 1994, Vol. 08(1) pp. 4; 1996, Vol. 10(1) pp. 4.
and peptides, 1989, Vol. 03(3) pp. 7; 1993, Vol. 07(1) pp. 4; 1993, Vol. 07(4) pp. 4; 1998, Vol. 12(1) pp. 1.
and physical delays, 1987, Vol. 01(2) pp. 6
and self-injuring behaviors, 1987, Vol. 01(2) pp. 1; 1988, Vol. 02(2) pp. 4; 1990, Vol. 04(1) pp. 1; 1991, Vol. 05(3) pp. 4; 1992, Vol. 06(1) pp. 1; 1993, Vol. 07(1) pp. 4; 1998, Vol. 12(1) pp. 6.
and socialization impairment, 1987, Vol. 01(2) pp. 1
and stereotypies, 1987, Vol. 01(4) pp. 4; 1990, Vol. 04(4) pp. 4; 1991, Vol. 05(4) pp. 2.
Oppenheim, Rosalind, 1990, Vol. 04(4) pp. 2; 1991, Vol. 05(4) pp. 3.
oppositional behaviors, 1998, Vol. 12(2) pp. 2
oppositional model of drug tolerance, 2003, Vol. 17(2) pp. 4
Options Program, 1988, Vol. 02(2) pp. 2
ORAP (pimozide), 2000, Vol. 14(1) pp. 4
ordered subset analysis, 2003, Vol. 17(1) pp. 6
O'Regan, Maire, 1993, Vol. 07(1) pp. 6
O'Reilly, Brenda A.
ORG 2766, 1991, Vol. 05(1) pp. 4; 1992, Vol. 06(4) pp. 4.
organic acid testing, 2000, Vol. 14(1) pp. 7
organophosphates, 2003, Vol. 17(1) pp. 6
organosphosphate insecticide chlorpyrifos (CPF), 2004, Vol. 18(3) pp. 6
Orient, Jane, 1999, Vol. 13(3) pp. 1
orientation in space, 1987, Vol. 01(3) pp. 3; 1988, Vol. 02(4) pp. 3; 1998, Vol. 12(3) pp. 3. See also balance
Orlich, Felice, 2002, Vol. 16(1) pp. 5
Ornitz, Edward, 1991, Vol. 05(2) pp. 3
Orthogenic School, 1990, Vol. 04(2) pp. 1; 1990, Vol. 04(4) pp. 6.
orthomolecular medicine. See Biological Therapy, immunotherapy, supplements
Orum, Alena, 1991, Vol. 05(3) pp. 4
Osborne, Allan, Jr., 1993, Vol. 07(4) pp. 2
Osmond, Humphrey, 1998, Vol. 12(2) pp. 3
osteoporosis, l 2001, Vol. 15(2) pp. 4
Osterling, Julie, 1994, Vol. 08(3) pp. 4; 1999, Vol. 13(1) pp. 1.
otitis media. See ear infections
Ouija Board effect, 1991, Vol. 05(1) pp. 1; 1992, Vol. 06(1) pp. 3; 1992, Vol. 06(3) pp. 7.
Our Toxic World: Who is Looking After our Kids? (Buttram and Piccolo), 1998, Vol. 12(1) pp. 3
over-questioning, 1996, Vol. 10(2) pp. 5
"overprompted teaching ," 1994, Vol. 08(1) pp. 6
overteaching, 1994, Vol. 08(2) pp. 5
oxidative stress, 2004, Vol. 18(4) pp. 1
Oxman, Joel, 1991, Vol. 05(1) pp. 7
oxytocin
and affiliative bahaviors, 1992, Vol. 06(3) pp. 4; 1993, Vol. 07(4) pp. 4; 1996, Vol. 10(3) pp. 2; 2001, Vol. 15(1) pp. 4; 2002, Vol. 16(4) pp. 5.
and magnesium, 1996, Vol. 10(3) pp. 2
and memory types, 2001, Vol. 15(1) pp. 4
and mood, 1996, Vol. 10(3) pp. 2
and naltrexone, 1996, Vol. 10(3) pp. 2
pitocin during labor and autism linked, 1996, Vol. 10(3) pp. 2
for repetitive behaviors, 2002, Vol. 16(4) pp. 5
in utero and autism, 1997, Vol. 11(4) pp. 7
Oyewumi, L.K., 1997, Vol. 11(3) pp. 4
Ozonoff, Sally, 1998, Vol. 12(2) pp. 5; 1998, Vol. 12(3) pp. 7.
© copyright 2005, 2006 Autism Research Institute
|
|
